Evidence map›Paper›PMID 35931096›Full record

ArticleThe Lancet. Infectious diseases2022

Monkeypox: how will we know if the treatments work?

Amanda Rojek, Jake Dunning, Piero Olliaro

Abstract read
In one paragraph

Article in The Lancet. Infectious diseases, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed.

  1. Treatment of mpox with tecovirimat under expanded access use in the Central African Republic.International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases · 2026
    Article
  2. Clinical Characterization and Outcomes of Human Clade IIb Mpox Virus Disease: A European Multicenter Mpox Observational Cohort Study (MOSAIC).Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2025
    Observational
  3. Article
  4. Article
  5. Article
  6. Mpox: The alarm went off. Have we gone back to sleep?PLoS neglected tropical diseases · 2024
    Article
  7. Article
  8. Variability in clinical assessment of clade IIb mpox lesions.International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases · 2023
    Article
  9. Review
  10. Mpox-A Rapidly Evolving Disease.JAMA dermatology · 2023
    Article
  11. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Amanda RojekInternational Severe Acute Respiratory and Emerging Infections Consortium, Pandemic Sciences Institute, University of Oxford, Oxford OX3 7DQ, UK; Emergency Department, Royal Melbourne Hospital, Melbourne, VIC, Australia. Electronic address: amanda.rojek@ndm.ox.ac.uk.
Jake DunningInternational Severe Acute Respiratory and Emerging Infections Consortium, Pandemic Sciences Institute, University of Oxford, Oxford OX3 7DQ, UK; Department of Infectious Diseases, Royal Free London NHS Foundation Trust, London, UK.
Piero OlliaroInternational Severe Acute Respiratory and Emerging Infections Consortium, Pandemic Sciences Institute, University of Oxford, Oxford OX3 7DQ, UK.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Mpox, MonkeypoxDisease OutbreaksHumansMonkeypox virus

Identifiers

PMID35931096
PMCPMC9629677

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.